U.S. Food and Drug Administration Office of Medical Products and Tobacco
E886015
The U.S. Food and Drug Administration Office of Medical Products and Tobacco is an FDA division responsible for overseeing the safety, effectiveness, and regulation of medical products and tobacco in the United States.
All labels observed (1)
| Label | Occurrences |
|---|---|
| U.S. Food and Drug Administration Office of Medical Products and Tobacco canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T10790396 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: U.S. Food and Drug Administration Office of Medical Products and Tobacco Context triple: [White Oak, Maryland, isNearFederalFacility, U.S. Food and Drug Administration Office of Medical Products and Tobacco]
-
A.
Center for Tobacco Products
The Center for Tobacco Products is the U.S. FDA division responsible for regulating the manufacture, marketing, and distribution of tobacco products to protect public health.
-
B.
Food and Drug Administration
The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
-
C.
Office of Regulatory Affairs
The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
-
D.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
E.
Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: U.S. Food and Drug Administration Office of Medical Products and Tobacco Target entity description: The U.S. Food and Drug Administration Office of Medical Products and Tobacco is an FDA division responsible for overseeing the safety, effectiveness, and regulation of medical products and tobacco in the United States.
-
A.
Center for Tobacco Products
The Center for Tobacco Products is the U.S. FDA division responsible for regulating the manufacture, marketing, and distribution of tobacco products to protect public health.
-
B.
Food and Drug Administration
The Food and Drug Administration is a U.S. federal agency responsible for protecting public health by regulating food, drugs, medical devices, and other consumer products.
-
C.
Office of Regulatory Affairs
The Office of Regulatory Affairs is the U.S. FDA’s primary field organization responsible for inspecting regulated products and manufacturers, enforcing compliance, and overseeing import operations to protect public health.
-
D.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
E.
Center for Biologics Evaluation and Research
The Center for Biologics Evaluation and Research is the U.S. regulatory body responsible for overseeing the safety, efficacy, and quality of biological products such as vaccines, blood products, and gene therapies.
- F. None of above. chosen
Statements (44)
| Predicate | Object |
|---|---|
| instanceOf |
office within a federal agency
ⓘ
sub-agency of the U.S. Food and Drug Administration ⓘ |
| alsoKnownAs |
FDA Office of Medical Products and Tobacco
NERFINISHED
ⓘ
Office of Medical Products and Tobacco NERFINISHED ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| goal |
ensure timely access to safe and effective medical products
ⓘ
reduce harm from medical products and tobacco use ⓘ regulate manufacture, distribution, and marketing of tobacco products ⓘ |
| hasResponsibility |
ensuring effectiveness of medical products
ⓘ
ensuring quality of medical products ⓘ ensuring safety of medical products ⓘ oversight of tobacco product regulation ⓘ protecting public health through regulation of medical products and tobacco ⓘ |
| hasRole |
cross-center harmonization of regulatory approaches
ⓘ
facilitating lifecycle regulation of medical products ⓘ policy coordination for medical products and tobacco ⓘ strategic planning for medical product and tobacco regulation ⓘ supporting implementation of tobacco control laws ⓘ |
| jurisdiction |
United States government
ⓘ
surface form:
federal government of the United States
|
| legalBasis |
Family Smoking Prevention and Tobacco Control Act
NERFINISHED
ⓘ
Federal Food, Drug, and Cosmetic Act NERFINISHED ⓘ |
| locatedInTheAdministrativeTerritorialEntity |
Maryland
NERFINISHED
ⓘ
United States NERFINISHED ⓘ |
| location | Silver Spring, Maryland NERFINISHED ⓘ |
| oversees |
Center for Biologics Evaluation and Research
NERFINISHED
ⓘ
Center for Devices and Radiological Health NERFINISHED ⓘ Center for Drug Evaluation and Research NERFINISHED ⓘ Center for Tobacco Products NERFINISHED ⓘ Office of Special Medical Programs NERFINISHED ⓘ |
| parentOrganization | U.S. Food and Drug Administration NERFINISHED ⓘ |
| partOf |
FDA medical product centers coordination structure
ⓘ
U.S. Department of Health and Human Services NERFINISHED ⓘ |
| regulates |
biologics
ⓘ
human drugs ⓘ medical devices ⓘ medical products ⓘ tobacco product distribution ⓘ tobacco product labeling ⓘ tobacco product manufacturing ⓘ tobacco product marketing ⓘ tobacco products ⓘ |
| sector |
medical product regulation
ⓘ
public health regulation ⓘ tobacco regulation ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: U.S. Food and Drug Administration Office of Medical Products and Tobacco Description of subject: The U.S. Food and Drug Administration Office of Medical Products and Tobacco is an FDA division responsible for overseeing the safety, effectiveness, and regulation of medical products and tobacco in the United States.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.
White Oak, Maryland
→
isNearFederalFacility
→
U.S. Food and Drug Administration Office of Medical Products and Tobacco
ⓘ